Registrar Corp

HomeDrugsDrug Master Files (DMF)DMF ExamplesType IV DMFs › U.S. FDA Labrasol Regulations

Filing a DMF for Labrasol with the U.S. FDA

Filing a drug master file (DMF) for Labrasol can be a useful mechanism to market your Labrasol to the U.S. Drug Industry. Typical Labrasol producers who have filed a DMF for Labrasol include:

  - Gattefosse Establissements

Registrar Corp can help you to properly prepare and submit your Labrasol DMF to FDA.

As your Agent, Registrar Corp will perform the following administrative functions:

  - Format, assemble and deliver your Labrasol DMF to FDA
  - Submit letters of authorization regarding your Labrasol to FDA
 - Provide changes, additions and maintenance of your Labrasol DMF
  - Respond to issues relating to ownership of your Labrasol DMF
  - Assist with submission of responses to FDA concerning your Labrasol DMF
  - Perform any required annual updates for your Labrasol DMF

For more information about filing a DMF for Labrasol, simply click below:

Live Help

U.S. FDA Regulations:

U.S. FDA DMF Regulation: 21 C.F.R. Section 314.420

Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2017 Registrar Corp
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco